FIELD: medicine.
SUBSTANCE: before prescribing contraception, polymorphous locus rs936306 of CYP19A1 gene is determined. If observing the genotype G/A detected, transient disorders for the first 6-6.5 months of the prescribed contraception is diagnosed; if observing the genotype A/A, side effects are diagnosed starting from the 7th months of the contraception.
EFFECT: technique according to the invention enables reducing a rate of side effects of the hormonal contraception, predicting the tolerance and safety of the hormonal contraceptives and the potential effect on the hepatic function, homeostasis system and blood lipids.
3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR HORMONAL CONTRACEPTION | 2002 |
|
RU2222331C2 |
| METHOD OF TREATING BENIGN HYPERPLASTIC PROCESSES OF FEMALE REPRODUCTIVE SYSTEM | 2011 |
|
RU2471485C1 |
| METHOD FOR PREVENTION OF OXIDATIVE STRESS ACCOMPANYING ADMINISTRATION OF RELEASING-HORMONE CONTRACEPTIVE SYSTEM | 2014 |
|
RU2563178C1 |
| METHOD OF PUBERTY METRORRHAGIA TREATMENT | 2006 |
|
RU2327462C1 |
| METHOD OF EARLY DIAGNOSTICS OF REASONABILITY OF CONSERVATIVE TREATMENT OF INTERNAL ENDOMETRIOSIS OF CORPUS UTERI | 2011 |
|
RU2459582C1 |
| 0 |
|
SU1777845A1 | |
| AGENT AND METHOD FOR RECURRENT OVARIAN CYST PREVENTION | 2008 |
|
RU2364411C1 |
| METHOD FOR UTERINE BLEEDING CONTROL DURING PUBERTY | 2007 |
|
RU2339392C1 |
| METHOD FOR PATIENT-SPECIFIC PREDICTION OF OESTROGEN-DEPENDENT DISEASES IN HEALTHY FEMALES AND FEMALES WITH CARDIOVASCULAR RISK FACTORS AGED 35-45 YEARS | 2013 |
|
RU2536829C1 |
| METHOD OF CHOOSING THERAPEUTIC APPROACH IN MENSTRUAL DISORDERS IN ADOLESCENT GIRLS WITH OVERWEIGHT | 2010 |
|
RU2422824C1 |
